Suppr超能文献

4. 全面的医学评估和共病评估:2023 年糖尿病护理标准。

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.

出版信息

Diabetes Care. 2023 Jan 1;46(Suppl 1):S49-S67. doi: 10.2337/dc23-S004.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的“糖尿病护理标准”包括 ADA 当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA 专业实践委员会的成员是一个多学科专家委员会,负责每年更新护理标准,或在必要时更频繁地更新。有关 ADA 标准、声明和报告的详细描述,以及 ADA 临床实践建议的证据分级系统和专业实践委员会成员的完整列表,请参阅简介和方法。希望对护理标准发表意见的读者,请在 professional.diabetes.org/SOC 上发表意见。

相似文献

1
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S49-S67. doi: 10.2337/dc23-S004.
2
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004.
4
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S43-S51. doi: 10.2337/dc24-S003.
6
17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017.
7
7. Diabetes Technology: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
8
6. Glycemic Targets: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
9
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: .
Diabetes Care. 2021 Jan;44(Suppl 1):S40-S52. doi: 10.2337/dc21-S004.
10
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.

引用本文的文献

2
Adaptation of Risk Score for Hepatocellular Carcinoma Without Alcohol Measures.
JAMA Netw Open. 2025 Jul 1;8(7):e2522305. doi: 10.1001/jamanetworkopen.2025.22305.
3
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping Review.
Can Liver J. 2025 Feb 25;8(1):63-78. doi: 10.3138/canlivj-2024-0050. eCollection 2025 Feb.
7
Predictors of smoking abstinence among diabetic smokers: Evidence from the French national smoking cessation registry CDTnet.
PLoS One. 2025 Jun 20;20(6):e0321764. doi: 10.1371/journal.pone.0321764. eCollection 2025.
8
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.
Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

本文引用的文献

1
"It Just Kind of Feels Like a Different World Now:" Stress and Resilience for Adolescents With Type 1 Diabetes in the Era of COVID-19.
Front Clin Diabetes Healthc. 2022 Feb 21;3:835739. doi: 10.3389/fcdhc.2022.835739. eCollection 2022.
2
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):511-522. doi: 10.1016/S2468-1253(23)00068-7. Epub 2023 Mar 16.
3
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
4
Diabetes and cirrhosis: Current concepts on diagnosis and management.
Hepatology. 2023 Jun 1;77(6):2128-2146. doi: 10.1097/HEP.0000000000000263. Epub 2023 Jan 13.
5
Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study.
Sci Diabetes Self Manag Care. 2022 Dec;48(6):522-532. doi: 10.1177/26350106221125701. Epub 2022 Sep 24.
7
Management of NAFLD in primary care settings.
Liver Int. 2022 Nov;42(11):2377-2389. doi: 10.1111/liv.15404. Epub 2022 Sep 1.
8
Improving Quality Outcomes: The Value of Diabetes Care and Education Specialists.
Clin Diabetes. 2022 Summer;40(3):356-365. doi: 10.2337/cd21-0089.
9
The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes.
Diabetes Care. 2023 Feb 1;46(2):228-236. doi: 10.2337/dc21-2495.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验